Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. APDN
APDN logo

APDN Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
3.71M
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
-2.08M
EV/OCF(TTM)
--
P/S(TTM)
0.28
Applied DNA Sciences, Inc. is a biotechnology company. The Company is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Company operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.
Show More

Events Timeline

(ET)
2025-09-29
15:14:27
Applied DNA reveals private placement plan to raise up to $58M for BNB treasury initiation.
select
2025-07-24 (ET)
2025-07-24
09:10:50
Applied DNA Sciences announces new follow-on LineaDNA order
select
2025-07-07 (ET)
2025-07-07
09:09:31
Applied DNA regains compliance with Nasdaq continued listing requirements
select
2025-06-30 (ET)
2025-06-30
09:25:45
Applied DNA Sciences announces restructuring, 27% workforce reduction
select
2025-06-17 (ET)
2025-06-17
16:32:01
Applied DNA Sciences CEO James Hayward to retire, Judy Murrah to succeed
select
2025-05-29 (ET)
2025-05-29
08:27:16
Applied DNA Sciences announces 1-for-15 reverse stock split
select
2025-04-21 (ET)
2025-04-21
09:06:25
Applied DNA's LineaRx 'ready to support' reshoring of drug development
select
2025-04-08 (ET)
2025-04-08
09:09:37
Applied DNA regains compliance with Nasdaq minimum bid price rule
select
2025-04-01 (ET)
2025-04-01
09:48:38
Applied DNA positions TR8 PGx testing as pre-emptive for therapeutic safety
select

News

Benzinga
9.0
2025-09-30Benzinga
Wolfspeed Shares Surge Over 50%; Check Out 20 Stocks Making Moves in Premarket Trading
  • Wolfspeed's Reorganization: Wolfspeed, Inc. announced a court-approved reorganization plan that will reduce its debt by 70% and interest payments by 60%, leading to a 50.9% increase in its stock price during pre-market trading.

  • Other Notable Stock Movements: Several companies saw significant pre-market trading gains, including Sunrise New Energy Co. (up 97%) and Vivakor, Inc. (up 67%), while others like Epsium Enterprise Limited and Artelo Biosciences, Inc. experienced notable declines.

Newsfilter
8.5
2025-09-29Newsfilter
Applied DNA Sciences Unveils Private Placement of Up to $58 Million to Launch BNB Treasury Strategy and Generate Native Yield for BNB
  • Investment and Strategy Overview: Applied DNA Sciences announced a $58 million PIPE offering led by institutional investors to initiate a digital asset treasury strategy focused on BNB, the native cryptocurrency of Binance, aiming to enhance yield through active management and integration of DeFi protocols.

  • Leadership and Advisory Appointments: The company appointed notable figures, including Anthony Scaramucci and Patrick Horsman, to strengthen its advisory team, while also announcing a leadership change with Clay Shorrock as the new CEO, emphasizing a strategic focus on the BNB ecosystem for growth and value creation.

Benzinga
8.5
2025-07-01Benzinga
Why Thumzup Media Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
  • Thumzup Media Corporation's Stock Surge: Thumzup Media Corporation's shares rose 20.4% to $8.45 in pre-market trading following the announcement of a $6.5 million registered direct offering.

  • Pre-Market Trading Highlights: Several stocks experienced significant movements, with BioNexus Gene Lab Corp surging 238.7% and Wag! Group Co falling 19.3%, reflecting a volatile trading environment.

SeekingAlpha
5.0
2025-06-17SeekingAlpha
Applied DNA Chairperson and CEO James A. Hayward resigns
  • Leadership Change: James A. Hayward is retiring as Chairperson and CEO of Applied DNA Sciences, effective June 18, 2025, with Judy Murrah appointed as his successor.

  • Stock Performance: Following the announcement, shares of Applied DNA Sciences fell by 2.95% in extended trading.

TipRanks
9.0
2025-06-01TipRanks
Upcoming Stock Splits This Week (June 2 to June 6) – Stay Invested
  • Upcoming Stock Splits: Several companies, including ARB IOT Group, Lyell Immunopharma, and Mullen Automotive, are implementing reverse stock splits to comply with Nasdaq listing requirements, effective from June 2 to June 3.

  • Purpose of Stock Splits: Stock splits, whether traditional or reverse, aim to adjust share prices for market compliance or to attract investors, while maintaining the overall market value of the company.

Benzinga
5.0
2025-04-01Benzinga
Why Applied DNA Sciences (APDN) Stock Is Rising
  • Stock Performance: Applied DNA Sciences Inc (APDN) shares rose by 6.0% to $1.76 after announcing its TR8 PGx pharmacogenomics testing as pre-emptive testing for therapeutic safety, specifically targeting patients with DPYD gene variants.

  • Future Plans: The company plans to enhance its TR8 PGx testing service with additional specialized subpanels in oncology, cardiology, and psychiatry to improve clinical decision-making and promote the adoption of pharmacogenomics testing.

Valuation Metrics

The current forward P/E ratio for Applied DNA Sciences Inc (APDN.O) is -0.03, compared to its 5-year average forward P/E of -2.31. For a more detailed relative valuation and DCF analysis to assess Applied DNA Sciences Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-2.31
Current PE
-0.03
Overvalued PE
0.35
Undervalued PE
-4.96

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.68
Current PS
0.00
Overvalued PS
2.64
Undervalued PS
0.72

Financials

AI Analysis
Annual
Quarterly

Whales Holding APDN

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Applied DNA Sciences Inc (APDN) stock price today?

The current price of APDN is 0 USD — it has increased 0

What is Applied DNA Sciences Inc (APDN)'s business?

Applied DNA Sciences, Inc. is a biotechnology company. The Company is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Company operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.

What is the price predicton of APDN Stock?

Wall Street analysts forecast APDN stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for APDN is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Applied DNA Sciences Inc (APDN)'s revenue for the last quarter?

Applied DNA Sciences Inc revenue for the last quarter amounts to 304.39K USD, decreased -35.62

What is Applied DNA Sciences Inc (APDN)'s earnings per share (EPS) for the last quarter?

Applied DNA Sciences Inc. EPS for the last quarter amounts to -33.99 USD, decreased -102.90

How many employees does Applied DNA Sciences Inc (APDN). have?

Applied DNA Sciences Inc (APDN) has 46 emplpoyees as of March 31 2026.

What is Applied DNA Sciences Inc (APDN) market cap?

Today APDN has the market capitalization of 3.71M USD.